Biochemical Hepatic Changes in Chronic Hepatitis C Patients Induced by Sofosbuvir and Daclatasvir with or without Ribavirin Regimens

Serum markers in monitoring the outcome of Sofosbuvir-based treatments in HCV genotype 4 Egyptian patients

Correlation between platelet count and outcome of chronic HCV patients treated with direct-acting antivirals

Safety and Efficacy of Ombitasvir, Paritaprevirand Ritonavir Combination with Ribavirin for Treatment of Chronic Hepatitis C Virus in Advanced Kidney Diseases Patients in Upper E

Study of the effects of Sofosbuvir based treatments on liver stiffness in chronic Hepatitis C patients using transient Elastography

Effect of viral load on hepatic fibrosis in patients with chronic hepatitis B patients: assessed by fibroscan

Non-invasive Evaluation of Liver Fibrosis Changes in Patients with Chronic ‎Hepatitis C after Directly Acting Antiviral Drugs

Study of Fibro Q Index as a Non invasive Method to Predict Liver Fibrosis in Chronic Hepatitis C

MOLECULAR AND BIOCHEMICAL STUDIES ON HEPATITIS C PATIENTS RELAPSED AFTER SOFOSBUVIR TREATMENT

Study the Effect of Sofosbuvir, Daclatasvir and Ribavirin on Hematologic Profile, ‎Vitamin B12 and Folic Acid Levels in HCV-Related Cirrhotic Patients‎